Skip to main content
Atezolimab plus bevacizumab prompts strong early response in unresectable HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Atezolimab plus bevacizumab prompts strong early response in unresectable HCC
User login
Username
Password
Reset your password
Concept
Lead
score
Hepatocellular Carcinoma
1
1
Biologic Therapy
0
1
Angiogenesis Inhibitors
0
0.91
Humanized Monoclonal Antibody
0
0.91
Cancer
0
0.36
Fatigue
0
0.18
Hospital
0
0.18
Tumor
0
0.18
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Gastroenterology
0
0.57
Hospital Medicine
0
0.18
Edit Tags